MAb for symptomatic COVID-19 in correctional facilities: an important opportunity
- PMID: 33617772
- PMCID: PMC7906645
- DOI: 10.1016/S0140-6736(21)00354-8
MAb for symptomatic COVID-19 in correctional facilities: an important opportunity
References
-
- US Food and Drug Administration Coronavirus (COVID-19) update: FDA authorizes monoclonal antibodies for treatment of COVID-19. Nov 21, 2020. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19...
-
- Reinhart E, Chen DL. Incarceration and its disseminations: COVID-19 pandemic lessons from Chicago's Cook County Jail. Health Aff (Millwood) 2020;39:1412–1418. - PubMed
-
- McGinley L. Monoclonal antibodies: overburdened hospitals are not offering this treatment against COVID-19. Dec 31, 2020. https://www.washingtonpost.com/health/2020/12/31/covid-monoclonal-antibo...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources